The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2023-07 · 15 (3)
DOI: 10.1002/dad2.12463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 13.08.2023. Verfasst von Silke White und 6 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Neurodegenerative Diseases (DZNE) Dresden Saxony Germany. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Introduction
Both elevated cortisol and hippocampal volume have been linked to an increased risk for the development of Alzheimer's disease (AD). This longitudinal study assessed the effects of plasma cortisol on hippocampal atrophy and clinical progression rates in patients with mild cognitive impairment (MCI).
Methods
Patients with amnestic MCI ( n = 304) were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) based on availability of baseline plasma cortisol and hippocampal volume measures, assessed at baseline and during follow‐ups. We investigated associations between plasma cortisol, hippocampal volume, and risk of clinical progression to AD over a study period of up to 100 months (mean follow‐up time 36.8 months) using linear mixed models, Cox proportional hazards models, and Kaplan‐Meier estimators.
Results
Plasma cortisol predicted greater hippocampal atrophy, such that participants with higher cortisol showed faster decline in hippocampal volume over time (interaction: β = ‐0.15, p = 0.004). Small hippocampal volume predicted a higher risk of clinical progression to AD (haard ratio [HR] = 2.15; confidence in terval [CI], 1.64–2.80; p < 0.001). A similar effect was not found for cortisol (HR = 1.206; CI, 0.82–1.37; p = 0.670) and there was no statistical evidence for an interaction between hippocampal volume and cortisol on clinical progression (HR = 0.81; CI, 0.57–0.17; p = 0.260).
Discussion
Our findings suggest that higher cortisol predicts higher hippocampal atrophy, which in turn is a risk factor for progression to AD. Regulation of the hypothalamic‐pituitary‐adrenal axis through stress‐reducing lifestyle interventions might be a protective factor against hippocampal degeneration at the prodromal stage of AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- German Center for Neurodegenerative Diseases (DZNE) Dresden Saxony Germany.
- Institute for Medical Informatics and Biometry Faculty of Medicine Dresden University of Technology Dresden Saxony Germany.
- Department of Nuclear Medicine Charité-Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
- Biogen Digital Health Biogen Cambridge Massachusetts USA.
Förderung
- NIA NIH HHS
Zitieren
APA
White, S., Mauer, R., Lange, C., Klimecki, O., Huijbers, W., Wirth, M., & Alzheimer's Disease Neuroimaging Initiative (2023). The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 15(3). https://doi.org/10.1002/dad2.12463
Vancouver
White S, Mauer R, Lange C, Klimecki O, Huijbers W, Wirth M, et al. The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023;15(3). doi:10.1002/dad2.12463
BibTeX
@article{White2023,
author = {White, Silke and Mauer, René and Lange, Catharina and Klimecki, Olga and Huijbers, Willem and Wirth, Miranka and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2023},
volume = {15},
number = {3},
doi = {10.1002/dad2.12463}
}
EUVIMED